4Sun Y D, Chen Z M, Wei H, et al. Nanotechnology challenge : safety of nanomaterials and nanomedicines[J]. Asian J Pharmacodyn Pharmacokinet, 2007,7 ( 1 ) : 17-31.
5Si D Y, Liang W, Sun Y D, et al.Biomedical evaluation of nanomedicines [J]. Asian J Pharmaeodyn Pharmaeokinet, 2007,7 (2) : 83-96.
6Cheng T F, Sun Y D, Si D Y, et al. Attention on research of pharmacology and toxicology of nanomedicines[J]. Asian J Pharmacodyn Pharmacokinet, 2009,9 ( 1 ) : 25-27.
7Liu C X. Research and Development of Nanopharmaceuticals in China[J]. Nano Biotech Eengin, 2009,1 ( 1 ) : 1 - 18.
8Holsapple M P, Farland W H, Landry T D, et al. Research strategiefor safety evaluation of nanmotyerials, Part I : Toxicological and safety evaluation of nanomaterials, Current challenges and data needs[J]. Toxical Sci, 2005,88( 1 ) : 12-17.
9Balshaw D M, Philbert M, Suk W A. Research strategies for safety evaluation of nanomaterials, Part Ⅲ : Nanoscale technologies for assessing risk and improving public health[J]. Toxicol Sci, 2005,88(2 ) : 298-306.
10Tsuji J S,Maynard A D,Howard P C,et al. Reaserch strategies for safety evaluation of nanomaterials. Part IV: risk assessment of nanoparticles [J].Toxicol Sci, 2006,89( 1 ) :42-50.
